Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 621-626

  Hewitt, Stephen M ^a   Saunders, Grady F ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Alternative splicing; Differentiation; Transcription factor; Tumor suppressor gene; Wilms' tumor; WT1

Indexed keywords

GROWTH FACTOR; MESSENGER RNA; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXON; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARCINOMA, RENAL CELL; CELL CYCLE; EXONS; GENES, WILMS TUMOR; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; WILMS TUMOR;

EID: 0029943604     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Calt KM, Glaserl T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C and Houseman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520, 1990.
2. Gessler M, Poustka A, Cavenee W, Neve R, Orkin S and Bruns GAP: A zinc finer gene identified by chromosome jumping. Nature (Lond.) 343: 774-778, 1990.
3. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP and Rauscher FJ. III: Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 253: 1550-1553, 1991.
4. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, and Rauscher FJ III: Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257: 674-678, 1992.
5. Wang ZY, Madden SL, Deuel TF & Rauscher III FJ: The Wilms' tumor gene product, WT1, represses transcription of the plateletderived growth factor A-chain gene. J Biol Chem 267: 21999-22002, 1992.
6. Werner H, Rauscher FJ III, Sukhatme VP, Drummond IA, Roberts CT Jr, and LeRoith D: Transcriptional repression of the insulin-like growth factor I receptor (IGF-IR) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem 269: 12577-12582, 1994.
7. Harrington MA, Konicek B, Song A, Xia X, Fredricks WJ and Rauscher FJ III: Inhibition of colony-stimulating factor-1 promoter activity by the products ofthe Wilms' tumor locus. J Biol Chem 268: 21271-21275, 1993.
8. Rupprecht HD, Drummond IA, Madden, SL and Sukhatme VP: The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269: 6189-6206, 1994.
9. Goodyer P, Dehbi M, Torban E, Bruening W and Pelletier J: Repression of the retinoic acid receptor-a gene by the Wilms' tumor suppressor gene product, wt1. Oncogene 10: 1125-1129, 1995.
10. Ryan G, Steele-Perkins V, Morris JF, Rauscher FJ III and Dressier GR: Repression of Pax-2 by WT1 during normal kidney development. Development 121: 867-875, 1995.
11. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ III, and Kim SJ: Repression of the transforming growth factor-β1 gene by the Wilms' tumor suppressor WT1 gene product. Endocrinology 8: 595-602, 1994.
12. Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ III, and Saunders GF: Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Research (in press).
13. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman DE, and Jaenisch R: WT1 is required for early kidney development. Cell 74: 679-702, 1993.
14. Armstrong JF, Prichard-Jones K, Bickmore WA, Hastie ND and Bard JBL: The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech of Dev 40: 85-97, 1992.
15. Grubb GR, Yun K, Williams BRG, Eccles MR & Reeve AE: Expression of the WT1 protein in fetal kidneys and Wilms tumors. Lab Invest 71: 472-479, 1994.
16. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM and Housman DE: Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc Natl Acad Sci U.S.A. 88: 9618-9622, 1991.
17. Telerman A, Dodemont H, Degraef C, Galand P, Bauwens S, Van Oostveld T and Amson RB: Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene. Oncogene 7: 2545-2548, 1992.
18. Bickmore WA, Oghene K, Little MH, Seawright A, van Heyningen V, and Hastie ND: Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science (Washington DC), 257: 235-237, 1992.
19. Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez-Guisa JM, Madden SL, Rauscher FJ III, and Sukhatme VP: DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol Cell Biol 14: 3800-3809, 1994.
20. Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y and Hino O: A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nature Genet 9: 70-74, 1995.
21. Yeung RS, Xiao G-H, Jin F, Lee W-C, Testa JR and Knudson AG: Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA 91: 11413-11416, 1994.
22. Funaki K, Everitt J, Oshmura M, Freed JJ, Knudson AG Jr and Walker C: Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6. Cancer Res 51: 181-186, 1988.
23. Oka T, Rairkar A and Chen JH: Structural and functional analysis of the regulatory sequences ofthe ets-1 gene. Oncogene 6: 2077-2083, 1991.
24. Freshney RI: Culture of Animal Cells: a Manual of Basic Technique, New York: Wiley-Liss, 1994.
25. Garvin AJ, Re GG, Tarnowski BI, Hazen-Marin DJ and Sens DA: The G401 cell line, utilized for study of chromosomal changes in Wilms' tumor is derived from a rhabdoid tumor ofthe kidney. Am J Pathol 142: 375-379, 1993.
26. Wheater PR, Burkitt HG and Daniels VG: Functional Histology, pp. 2-34. New York: Churchhill Livingstone, 1987.
27. 1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes. Proc Natl Acad Sci U.S.A. 92: 4517-4521, 1995.
28. Genetics Computer Group Program Manual for the GCG Package, Version 7. Madison, WI: University of Wisconsin 1991.
29. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP and Rauscher FJ III: Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 6: 2339-2348, 1991.
30. Jameson BA and Wolf H: The antigenic index: a novel algorithim for predicting antigenic determinants. Comput Appl Biosci 4: 181-186, 1988.
31. Haber DA, Park S, Maheswaran S, Englert C, Re GG, Hazen-Martin DJ, Sens DA and Garvin J: WTI-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science (Washington DC) 262: 2057-2059, 1993.